Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
thats awesome cause I like tastier, seriously, like to eat my weed!
Findit, Inc. Announces Second Topical CBD Purchase Orders From Same Two Major Retailers Weeks after Pilot Program Shipped
Press Release | 08/12/2019
ATLANTA, GA / ACCESSWIRE / August 12, 2019 / Findit, Inc. a Nevada Corporation (OTC PINK:FDIT) has received its second purchase orders from two major retailers for the CBD line Urban Collective. The purchase orders consist of four topical essential oils. Findit announced on July 23, 2019 it received its first orders for its CBD Topical Oil. The first orders were part of a pilot program to test the line out and monitor in store sales. With approximately 2,300 retail locations, they provided a second P.O. for approximately a fifty percent increase from the first order. The second order came in prior to the first order hitting the shelves. Revenues from the purchase orders will be booked in the third quarter, ending September 30, 2019. The combined P.O.s alone, currently increase revenue over the same quarter of 2018 without including Findit, Inc's online marketing services through August 12, 2019.
Clark St. Amant stated, "The additional P.O.s from the same two major retailers within weeks after our pilot program shipped, is a positive sign for Findit. We are taking meetings with other well known National Retailers to either carry our Urban Collective CBD line, or create a private label line for themselves. The upside of working B2B is that Findit is able to private label for each of our buyers in the event that is what they require. With our L.A. based branding and sales division being built out, the focus is to increase revenue while increasing profit margins across Findit's different revenue streams. We see the CBD space as one of these areas we can capitalize on both with B2B sales and our online marketing services."https://www.otcmarkets.com/stock/FDIT/news/Findit-Inc-Announces-Second-Topical-CBD-Purchase-Orders-From-Same-Two-Major-Retailers-Weeks-after-Pilot-Program-Shipped?id=236984
looks like mother nature is the only one that can help the stock price get "bigger, tastier and more dense"...lol.
“Growing outside is a dream,” said Derek Pedro, chief cannabis officer at WeedMD, during a tour of the farm in Strathroy, about 225 kilometres (140 miles) from Toronto. He said the natural changes in light and temperature outside result in “bigger, tastier, denser” buds with a better high than the same strain grown in a greenhouse.
TORONTO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (WDDMF) (4WE.F) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report preliminary unaudited revenues of $8 million for the three months ending June 30, 2019. Taking into consideration its sales from the medical, adult-use and wholesale markets, WeedMD increased its net revenues quarter-over-quarter by more than 140% to $8 million. The interim financial results for the three and six month period ending June 30, 2019, will be released on August 29, 2019. The information contained herein may change based on final results.
“WeedMD continues to execute on multiple fronts and we are pleased to announce another record quarter,” said Keith Merker, CEO of WeedMD. “With our industry-leading outdoor grow and recent licensing of another 20 cultivation and processing rooms at our Strathroy greenhouse (read press release here), WeedMD is positioned for continued growth and profitability.”
Q2 Conference Call
The Company will host a conference call with management on Thursday August 29, 2019 at 10 a.m. Eastern Time to report its Q2, 2019 financial results and operational outlook. The call will be hosted by Keith Merker, CEO and Nichola Thompson, CFO of WeedMD.
Management will be available for analyst and media questions following opening remarks.
Conference Call Details:
Date: Thursday August 29, 2019
Time: 10 a.m. Eastern Time
Dial-in Number: Canada/USA: 1-800-319-4610. International Toll: 1-604-638-5340
Participants, please dial in and ask to join the WeedMD call.
Replay Dial-in: Canada/USA: 1-800-319-6413. International Toll: 1-604-638-9010
Replay Access Code: 3544
Replay will be available after 12:00 p.m. Eastern Time, until September 29, 2019.
For more information, access WeedMD’s AGM investor presentation here and 2019 corporate video highlights here.
About WeedMD Inc.
WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse and outdoor facility located in Strathroy, ON. The Company also operates CX Industries, a wholly-owned subsidiary of WeedMD Inc. CX operates out of the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. WeedMD has a multi-channeled distribution strategy that includes selling directly to medical patients, strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where WeedMD’s adult-use brand Color Cannabis is sold.
Follow WeedMD & Color Cannabis:
Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://www.linkedin.com/company/weedmd/?originalSubdomain=fr
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/
&
Instagram: https://www.instagram.com/callitcolor/
TORONTO, Aug. 02, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (WDDMF) (4WE.F) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce it has secured a Health Canada licence amendment approval to expand production into ten additional 10,000 square foot cultivation rooms and ten new processing rooms at its state-of-the-art hybrid greenhouse in Strathroy, Ontario. Licensing of the 20 additional rooms and ancillary space more than doubles WeedMD’s licensed greenhouse production space in Strathroy. Additionally, 27-acres of outdoor grow on the property was licensed and planted in June of this year.
With a total of eighteen 10,000 square foot hybrid cultivation rooms now licensed, WeedMD’s annual greenhouse cannabis production capacity is more than 20,000 kgs, with more than 25,000 kgs of incremental biomass forecasted to be harvested from the outdoor cultivation in Q4, 2019. The 10 new processing rooms will be used for drying, trimming and processing cannabis.
“In the past year we have successfully expanded our production capacity more than 20-fold, and brought online an efficient quality-driven production platform that is recognized across Canada as a trusted source of medical-grade cannabis,” said Keith Merker, CEO of WeedMD. “The scalability of our production, together with our extraction capabilities at CX Industries, gives us the platform to continue delivering the results that our stakeholders expect.”
Current Licensed Production? in Strathroy
Eighteen 10,000 sq. ft. cultivation rooms, two 5,000 sq. ft. rooms for propagation
Total of 215,000 sq. ft. currently licensed for cultivation and sale?
Outdoor grow capacity of 27 acres or 1.18M sq. ft.
Licensed production capacity of over 50,000 kgs annually at full production
Future Production
Additional 308,000 sq. ft. in two traditional greenhouses ?expected to come online in early 2020
Additional 73 acres of outdoor production expected to come online in 2020
The Company recently announced the launch of affiliate CX Industries, an extraction hub that will operate out of its Aylmer, Ontario facility. Together with its greenhouse cultivation and outdoor grow that is in full operation, WeedMD is producing significant low-cost biomass input for its extraction and processing hub. For more information, access CX Industries’ website.
For more Company information, access WeedMD’s investor presentation here and 2019 corporate video highlights here.
About WeedMD Inc.
WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse and outdoor facility located in Strathroy, ON. The Company also operates CX Industries, a wholly-owned subsidiary of WeedMD Inc. CX operates out of the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. WeedMD has a multi-channeled distribution strategy that includes selling directly to medical patients, strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where WeedMD’s adult-use brand Color Cannabis is sold.
Follow WeedMD & Color Cannabis:
Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://www.linkedin.com/company/weedmd/?originalSubdomain=fr
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/
For further information, please contact:
WeedMD Inc.
Keith Merker, Chief Executive Officer
Tel: 519-765-2440 Ext. 222
Email: investor@weedmd.com
To learn more, visit us at www.weedmd.com
For Media Inquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com
Can only grow up from here! Our outdoor #cannabis plants are getting so tall and heavy that we've had to bring in some extra support. More news coming soon. #CannabisCanada
Can only grow up from here! Our outdoor #cannabis plants are getting so tall and heavy that we've had to bring in some extra support. More news coming soon. #CannabisCanada pic.twitter.com/IUY8577AY5
— Entourage Health (@EntourageHealth) August 1, 2019
I like me some WeedMD
https://finance.yahoo.com/news/cx-industries-signs-exclusive-agreement-111000752.html
month old WeedMD video
gooo WeedMD, mericann?
WeedMD Launches Cannabis Extraction Affiliate CX Industries
GlobeNewswire•July 23, 2019
Wholly-owned subsidiary to drive strategic partnerships in cannabis extraction and tolling
TORONTO, July 23, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (WDDMF) (4WE.F) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce it has launched CX Industries Inc. (“CX Industries” or “CX”), a wholly-owned subsidiary that will specialize in extraction, toll processing and third-party product formulation from WeedMD’s fully-licensed Aylmer, Ontario facility. CX Industries will have the capacity to process more than 200,000 kgs of biomass at its peak production in 2020.
“The launch of CX Industries represents the next step in the evolution of WeedMD. The marriage of consistent low-cost input material from our cultivation platform with our fully-licensed extraction hub in Aylmer truly sets us apart. Our management team is now working with strategic partners to provide a platform for entrepreneurs and seasoned brands to enter the concentrates market, building on our history of collaborating successfully with our peers in the cannabis industry,” said Keith Merker, CEO of WeedMD. “We have a solid reputation for executing on our production platforms – rooted in our integrity and transparency, combined with our ability to scale. CX offers world-class extraction and end-to-end production solutions as the market readies for the launch of extracts later this year.”
The Company recently announced the transition of its Aylmer, Ontario facility, now CX Industries, into a large-scale cannabis extraction and processing hub. Together with its greenhouse cultivation and outdoor grow that is in full operation at its Strathroy facility, WeedMD is producing significant low-cost biomass input for extraction. Read more here.
Details about CX Industries’ extraction facility:
Fully licensed for cannabis oil production and sale, having processed oils onsite since June 2017
Four fully-operational extraction lines to be brought progressively online starting in 2019 with the ability to process over 200,000 kgs of biomass annually at peak production
Ability to provide formulation capabilities for wholesale and white label manufacturing
Facility will be renovated to meet GxP* standards to support compliance for both domestic and international markets
Fully-licensed 26,000 sq. ft. facility is located on an expandable four-acre site wholly-owned by WeedMD
WeedMD will supply a large quantity of input material for cannabis extraction from both its hybrid greenhouse and outdoor production platforms at its Strathroy site
*GxP encompasses a broad range of compliance-related activities such as Good Laboratory Practices, Good Manufacturing Practices and Good Production Practices.
For more information, access WeedMD’s investor presentation here and 2019 corporate video highlights here.
About CX Industries Inc.
CX Industries is a wholly-owned subsidiary of WeedMD Inc. CX operates out of the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility and specializes in cannabis extraction and processing. The facility is located on four acres of expandable property owned by WeedMD. At peak production in 2020, CX is expected to extract and process more than 200,000 kgs of biomass annually.
About WeedMD Inc.
WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and distributor of cannabis products for both the medical and adult-use markets. The Company owns and operates two facilities: a 158-acre state-of-the-art greenhouse and outdoor facility located in Strathroy, Ontario and a 26,000 sq. ft. extraction and processing facility in Aylmer, Ontario operating as CX Industries Inc. The Company currently has 136,000 square feet of licensed indoor and greenhouse production space and is expected to have a total footprint of more than 550,000 square feet of indoor and greenhouse production online in 2019. Additionally, 27 acres or 1,176,000 sq. ft. of outdoor cultivation is licensed and fully operational with first harvest expected in October 2019. WeedMD has a multi-channeled distribution strategy that includes selling directly to medical patients, strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where WeedMD’s adult-use brand Color Cannabis is sold.
Follow WeedMD & Color Cannabis:
Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://www.linkedin.com/company/weedmd/?originalSubdomain=fr
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/
&
Instagram: https://www.instagram.com/callitcolor/
For further information, please contact:
WeedMD Inc.
Keith Merker, Chief Executive Officer
Tel: 519-765-2440 Ext. 201
Email: investor@weedmd.com
To learn more, visit us at www.weedmd.com
WeedMD is recovering nicely. I’m holding. They just need to start posting decent revenue numbers and move to bigger exchanges for their stock to gain wider appeal and move higher.
Awesome, buying high selling low!
Welcome to the worlds' greatest marijuana sector !
To - The Land of Milk and Honey !
Hey !.....
* I know : It'd certainly HELP if I read up on 'em a bit (instead of just drawing lines)....I get that :
And it looks like some guy's've been doin' a fair dinkum job of keeping the intro-page up-to-date - Thanks !
Not sure how You've been farin' because it sure has been rough....
Aye' How she's The Land of Milk and Honey eh ?
Or something ?.......
Canadian Licensed Producers (LPs) have once again become a focal point of the cannabis industry after recently coming under considerable pressure, a trend that we have been closely monitoring.
During the last month, Canadian LPs have been trending lower and we believe that this weakness is the result of two primary developments: 1) The firing of Bruce Linton as the CEO of Canopy Growth (WEED.TO) (CGC), and 2) The non-compliance notice issued by Health Canada to CannTrust Holdings (TRST.TO) (CTST).
Although the recent decline has been significant, we believe that the one-year self-implemented suspension on CannTrust will benefit other Canadian LPs. Canadian authorities expected CannTrust to be a major supplier to the medical and recreational market on a going-forward basis. The suspension created a significant loss for the current and future production capacity needs of the Canadian market, and this will benefit other LPs.
Historical trends lead us to believe that the Canadian cannabis market will continue to be under pressure over the near-term. After the recent weakness, valuations look much more attractive and we will continue to closely monitor this vertical of the cannabis industry. Today, we have highlighted 5 Canadian LPs that should benefit from the issues with CannTrust and believe that these are opportunities to be watching.
Download Our Report On 5 Canadian LP’s Leading The Outdoor Cultivation Trend
WeedMD: A Growth Story to be Watching
We believe that WeedMD Inc. (WMD.V) (WDDMF) is well positioned to capitalize on the recent issue with CannTrust and is an opportunity that we are closely following. Earlier this year, we visited the Aylmer facility and were beyond impressed with the scale of this operation. When you combine the company’s expanding indoor footprint with the recently planted outdoor cultivation footprint, you have a company with major growth prospects undervalued by the market.
Another reason we are excited about WeedMD is due to the focus on the cannabis concentrate market and expect this to be a major aspect of the business in 2020. Demand for cannabis concentrates continues to increase and are the input product required to create cannabis infused prodcuts. With Canada’s edible and cannabis oil market expected to open in the coming months, WeedMD will be well positioned to capitalize on this opportunity and should see strong demand for its products.
Based on the analysis we have conducted on the products purchased on the Ontario Cannabis Store (OCS), we can understand the high value of demand for WeedMD’s products, are amongst the first to sell out when new products are launched. We are bullish on the existing demand for the company’s products and expect to see the increasing demand quickly absorbed by the market.
Despite the recent pullback by the Canadian LPs, WeedMD continues to trade at a major discount to its peers. As the company continues to execute on its expansion, we expect to see fundamentals improve and will monitor how the team continues advance operations. WeedMD has significant catalysts for growth (the harvesting of the outdoor cultivation crop, the opening of the cannabis concentrate facility, and the completion of the expansion) and this is an opportunity that we continue to closely follow.
Seems like you might get your cheaper shares. .80-1.00 US seems doable, your .25 doomsday forecast is definitely an overreach.
"With a combined indoor and outdoor production footprint of over 5.2M sq. ft. and projected total annual output of 150,000 kgs of cannabis in 2020, the Company is well-positioned to become one of Canada’s largest cannabis producers."
This seems compelling for a mj stock under $2
The annual report was not too compelling. Company is not profitable. Future developments like bringing supply online could change the outlook for the better. Also, going to a major US exchange would help.
Just bought a small position again. I am really surprised this hasn’t moved higher. What’s holding us down?
WeedMD Confirms its Licensed and Scalable Outdoor Grow is Coming Online in Early June
GlobeNewswire•June 3, 2019
Fall 2019 Harvest to Provide Significant Low-Cost Biomass Input for its Extraction & Processing Hub
TORONTO, June 03, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to confirm that following the receipt of Health Canada’s licence for outdoor cultivation, WeedMD will begin planting more than 20,000 cannabis plants during the week of June 10, 2019 at its Strathroy, Ontario site. The Company expects to be the first licensed producer in Canada to start growing cannabis outdoors. Outdoor grow readiness video here.
“We are leading the way and making history as the first Canadian LP expected to bring outdoor cultivation online,” said Keith Merker, CEO of WeedMD. “We have a very experienced cultivation team led by our Chief Cannabis Officer Derek Pedro. This same team has successfully grown cannabis outdoors at scale for more than 10 years under Canada’s medical program. The 27-acres is primed and ready for our proven high-CBD and THC outdoor strains, which are already rooted and waiting to be planted.”
WeedMD also recently announced the transition of its Aylmer, Ontario facility into a cannabis extraction and processing hub. Read extraction news here. With the large volume of low-cost input material that the outdoor harvest will generate, the Company is positioned to process and market significant quantities of extracts and concentrates starting in Q4, 2019.
WeedMD Outdoor Cultivation:
Health Canada licence amendment secured on May 31, 2019
Phase I includes the first 27 of 100 available acres at its Strathroy property
Construction of fencing, security, irrigation and other required infrastructure is complete within a fully-funded $2 million budget
73 additional acres of production planned for Phase II in 2020 on the existing property
Municipal approval secured
Operational synergies with outdoor cultivation directly adjacent to WeedMD’s existing propagation operations within its licenced greenhouse facility
All infrastructure and staffing resources exist onsite with a proven team dedicated to the outdoor grow
WeedMD’s cultivation team brings significant experience growing cannabis outdoors locally
Selected strains proven to excel outdoors in southwestern Ontario
More than 20,000 plants already rooted in organic material and ready to be planted
Growing from rooted plants allows for higher yields, survival rates and consistency when compared to starting from seed
WeedMD Extraction Hub:
WeedMD is building on its experience in extract production, having processed oils onsite in Aylmer since June 2017
Aylmer site is fully licensed for cannabis oil production and sale
plans include four extraction lines in operation with the ability to process over 200,000 kgs of biomass annually
WeedMD will utilize various extraction methods in order to meet the demands of the market
Aylmer facility is being built to GxP* standards to support compliance for both domestic and international markets
WeedMD will provide formulation capabilities for wholesale and white label manufacturing
existing fully-licensed 26,000 sq. ft. facility is located on an expandable four-acre site wholly-owned by WeedMD
WeedMD will supply a sizeable quantity of input material for cannabis extraction from its large-scale greenhouse and also from its 27-acres of outdoor production from its Strathroy site
*GxP encompasses a broad range of compliance-related activities such as Good Laboratory Practices, Good Clinical Practices and Good Manufacturing Practices.
With a combined indoor and outdoor production footprint of over 5.2M sq. ft. and projected total annual output of 150,000 kgs of cannabis in 2020, the Company is well-positioned to become one of Canada’s largest cannabis producers.
Nice volume! Shorties selling to each other
TORONTO, May 31, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that it has secured Health Canada approval for 27 acres of low-cost, outdoor cultivation on its Strathroy, Ontario property. The Company will commence planting more than 20,000 clones in early June with plans to harvest in fall 2019, increasing potential production output by an additional 27,000 kgs.
With a combined indoor and outdoor production footprint of over 5.2 million sq. ft. and projected total potential annual output of 150,000 kgs of cannabis by 2020, WeedMD is now positioned to become one of Canada’s largest cannabis producers.
“Our ability to scale, coupled with our team’s proven experience in growing our proprietary genetics outdoors, positions us as a first-mover in the industry,” said Keith Merker, CEO of WeedMD. “We have put together the most compelling outdoor cultivation plan in the industry and this licence is the final piece of that plan to fall into place.”
WeedMD Outdoor Cultivation &
Outdoor Grow. 27-acre, low-cost, outdoor grow operation ready to plant, pending licensing. With expansion capabilities to more than 100 acres for a total yield of more than 100,000 kgs of outdoor cannabis planned for 2020.
Facilities and Production Update. An additional 10 hybrid cultivation rooms, each 10,000 sq. ft., are complete and are expected to be licensed once the outdoor licence is secured. The Company is also now in the late stages of completing the retrofit of two large traditional greenhouse rooms that will add more than 300,000 sq. ft. in 2019.
Licensing and Packaging Efficiencies. Secured a Health Canada licence amendment for an additional processing area equipped with semi-automated packaging lines at its Aylmer facility to increase speed to market and drive costs lower. Also secured a processing licence at the Strathroy facility.
Extraction Initiative. WeedMD is currently converting its fully-licensed Aylmer facility into a large-scale cannabis extraction and processing hub with an annual capacity to process more than 200,000 kgs of biomass.
Operating Metrics Improve.Margins continue to improve through increasing yields, economies of scale beginning to be realized as production expands, and a focus on refining processes.
Supply and Distribution Agreements. WeedMD secured additional provincial distribution agreements with Manitoba and Saskatchewan. Shipping to a total of six provinces across the country, the Company is now able to reach about 70% of Canada’s projected adult-use market.
Retail Initiative. WeedMD partnered with Pioneer Cannabis and Pita Pit to pursue opportunities in cannabis retail. A Master Cannabis Retail and Licensing Agreement was signed with an Ontario cannabis retail lottery winner who will own and operate the first Pioneer Cannabis store located at 1200 Brant Street in Burlington, Ontario.
We continue to deliver consistent improvement in our results, quarter-over-quarter,” said Nichola Thompson, CFO of WeedMD. “With the successful harvests from six additional grow rooms licensed at the end of 2018 now coming to market, we expect significant revenue increases throughout the balance of the year.”
For the three months ended March 31, 2019, WeedMD recorded net sales of $3.3M, representing a quarter-over-quarter increase of 23%.
The Company sold 793 kgs of dried cannabis, representing an increase of 46% from the previous quarter.
Improved gross profit margin to 15% (before changes in fair value).
The Company holds $13.9M of inventory and biological assets as of March 31, 2019, an increase of $5.9M or 74% from the prior quarter.
The all-in weighted average cost per gram for Q1 2019 was $2.90, compared to $3.28 for Q4 2018 and $3.66 in Q1 2018. This is inclusive of all costs, direct and indirect, to produce and package a gram of cannabis.
WeedMD purchased the 98-acre property in Strathroy where its 610,000 sq. ft. greenhouse facility and associated infrastructure reside, as well as the neighbouring 60-acre property. The Company funded the transaction with a $39M credit facility from BMO.
Fully-licensed facility to be optimized for extract and concentrate production with capacity of more than 200,000 kgs of biomass by 2020
TORONTO, May 29, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (WDDMF) (4WE.F) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that it is converting its fully-licensed 26,000 sq. ft. Aylmer, Ontario facility to a large-scale cannabis extraction and processing operation.
“WeedMD is optimizing its two licensed facilities to allow each to focus on a core vertical and to streamline our operations. We are transitioning the Aylmer site to produce a wide range of extracts and concentrates,” said Keith Merker, CEO of WeedMD. “All cultivation has been consolidated to our greenhouse and outdoor Strathroy facility, which is delivering consistently improving yields at increasingly competitive costs.”
Ive not heard onebut seen lots of interview's
Just wondering if this conference call is normal? If not, then perhaps they have news to talk about that is on its way.
Im not blaming management yet but something needs to be done. OTC sucks, this pps does not reflect future potential one bit
Has WeedMD always had conference calls with their quarterly reports?
The growth in Revenue has been there and is getting better. Problem is the cost of that revenue.
Strange ticker? Been here almost three years 12/19 and underwater most of it with lots of fantastic news along the way!
Wtf this ticker is undervalued and it feels like it’s unknown.
1st Quarter in 2 weeks, RSI is low, Hoping for a good run an Licenses for More Grow!
Look to enter here under $1.00
Target entry .25
"Just bitter I lost so much here last fall"
Well OK then.
What about technical requirements?
More of what they’ve been doing. Growing the business and revenue without share dilution. Exposure is the other half. Move to a major exchange and get some press about being an up and coming MJ company.
What would it take? Manipulation getting so old
WeedMD Revenue Surges 465% + Buy/Sell Signal & Chart
View here
Somebody likes last night's financial report. I see over 65,000 shares being bid to buy at $1.38. I thought it was a good report. Revenues were up big. We know they don't need to do dilutive financing since they have the bank line of credit.
Followers
|
22
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1213
|
Created
|
01/10/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |